This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday

Comments
Loading...

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • William Blair analyst Andy Hsieh initiated coverage on Elevation Oncology, Inc. ELEV with an Outperform rating. Elevation Oncology shares closed at $0.5951 on Thursday. See how other analysts view this stock.
  • William Blair analyst Sarah Schram initiated coverage on Denali Therapeutics Inc. DNLI with an Outperform rating. Denali Therapeutics shares closed at $20.84 on Thursday. See how other analysts view this stock.

Considering buying DNLI stock? Here’s what analysts think:

Read This Next:

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!